Day: April 14, 2025

Series  RIKV 25 0716 RIKV 25 1015Settlement Date  04/16/2025 04/16/2025Total Amount Allocated (MM)  9,730 27,230All Bids Awarded At (Price / Simple interest)  98.030 / 7.950 96.136 / 7.950Total Number of Bids Received  12 23Total Amount of All Bids Received (MM)  11,230 31,730Total Number of Successful Bids  9 20Number of Bids Allocated in Full  9 20Lowest Price / Highest Simple Interest Allocated  98.030 / 7.950 96.136 / 7.950Highest Price / Lowest Simple Interest Allocated  98.067 / 7.798 96.347 / 7.500Lowest Price / Highest Simple Interest Allocated in Full  98.030 / 7.950 96.136 / 7.950Weighted Average of Successful Bids (Price/Simple Interest)  98.056 / 7.843 96.185 / 7.845Best Bid (Price / Simple Interest)  98.067 / 7.798 96.347 / 7.500Worst Bid (Price / Simple Interest)  98.006 / 8.049 96.089 / 8.051Weighted...

XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on commercial sales at rates ranging from low single digits to mid-teens Holders of Kinnate Contingent Value Rights (CVRs) will receive 85% of all related upfront, milestone, and royalty payments paid to XOMA Royalty prior to April 2, 2029 EMERYVILLE, Calif., April 14, 2025 (GLOBE NEWSWIRE) — XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has completed the sale of all five pipeline assets that were acquired when XOMA Royalty closed its acquisition of Kinnate Biopharma Inc. on April 3, 2024.  Pursuant to the terms of the related asset purchase agreements, XOMA Royalty is entitled to upfront and milestone payments of up to $270 million and future royalty...

Data to be presented on Monday, April 28, 2025 CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) — Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association (AUA2025), taking place from April 26-29th in Las Vegas.Abstract OverviewAbstract Title: Prospective Open Label Study to Evaluate the Safety and Efficacy of Safety and Efficacy of intravesical sustained release Gemcitabine Docetaxel combination (NDV-01) in High Risk NMIBC: P2 on Apr 25Session: P2 (Paradigm-Shifting)Presentation Date: April 28, 2025Presentation Time 10:04 AM PT   About NDV-01NDV-01 is an investigational, innovative sustained-release formulation of two complementary, well-established, chemotherapy agents,...

LOUISVILLE, Ky., April 14, 2025 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage and media solutions, today announced that it will participate in the upcoming Planet MicroCap Showcase Conference in Las Vegas on April 23 and 24, 2025. Management will provide a general presentation, to be webcast live, on April 23 at 4:00 pm Pacific Time and host one-on-one meetings with investors all day on April 24. Individuals attending the conference are encouraged to contact Planet Microcap directly for meeting availability. About Creative Realities, Inc.Creative Realities designs, develops and deploys digital signage-based experiences for enterprise-level networks utilizing its ClarityTM, ReflectViewTM, and iShowroomTM Content Management System...

Vancouver, BC, April 14, 2025 (GLOBE NEWSWIRE) — American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) today announces that Ali Haji has been appointed as Chief Executive Officer. Murray Nye will assume the role of President, where he will continue to provide strategic guidance, advisory support, and leadership to the technical team as the Company continues to accelerate its long-term vision and advancing its flagship tungsten project, the IMA Mine.Mr. Haji brings over 20 years of metals and mining, investment management, publicly-listed capital markets experience, wherein he has served a variety of senior leadership roles. Mr. Haji serves as Chief Executive Officer and Director of ION Energy Ltd. (TSXV: ION) where he has led the company in advancing a portfolio of lithium assets, raising...

RENO, Nev., April 14, 2025 (GLOBE NEWSWIRE) — Android users can now wirelessly monitor and manage their Battle Born® smart battery systems through the newly released Battle Born Mobile App, available on the Google Play Store. Developed by Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and battery technology and maker of Battle Born Batteries®, the app works exclusively with batteries equipped with Dragonfly IntelLigence®—the Company’s proprietary smart battery technology. It delivers real-time data, system alerts, historical performance insights, and diagnostic capabilities to help users optimize their power systems. Whether powering an RV, off-grid home, or marine vessel, users can monitor individual batteries or entire battery banks, streamline troubleshooting,...

Awards in favour of Quantum BioPharma Totalling $180,000 upheld and is now due TORONTO, April 14, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today announced that the reconsideration motion by Dr. Raza Bokhari at the Court of Appeal for Ontario was dismissed entirely in favour of Quantum BioPharma. Dr. Raza Bokhari, current CEO of Medicus Pharma, Ltd., was CEO of FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) now Quantum BioPharma, in 2019 and was terminated for cause in July...

VANCOUVER, Canada, April 14, 2025 (GLOBE NEWSWIRE) — April 14, 2025 — Montage Gold Corp. (“Montage” or the “Company”) (TSXV: MAU, OTCQX: MAUTF) is pleased to announce that it has exercised its participation right to maintain its equity interest in Sanu Gold Corporation (“Sanu”) (CSE:SANU; OTCQB:SNGCF) following Sanu’s non-brokered private placement as announced on March 25, 2025 (the “Placement”). As a result, Montage has been issued 7,664,294 common shares of Sanu at a price of C$0.28 per share, paid for by way of the issuance of 848,222 common shares of Montage at a deemed price of C$2.53 per share, representing the 30-day VWAP at the time of Sanu’s announcement of the Placement, for a deemed consideration of approximately C$2.1 million, resulting in a 19.5% ownership in Sanu. Montage has rights to top up its equity interest...

EDMONTON, Alberta, April 14, 2025 (GLOBE NEWSWIRE) — TSX,NYSE: STN Stantec, a global leader in sustainable design and engineering, will release its first quarter 2025 financial results after markets close on Wednesday, May 14, 2025. On Thursday, May 15, 2025, at 7:00 AM Mountain Time (9:00 AM Eastern Time), Gord Johnston, president and chief executive officer, and Vito Culmone, executive vice president and chief financial officer, will hold a webcast and conference call to discuss the Company’s performance. Q1 2025 Webcast and Conference CallThursday, May 15, 2025 at 7:00 AM Mountain Time (9:00 AM Eastern Time)Go to Webcast Conference Call – Pre-registration is recommended To participate in the Q&A, please register: Conference Call Registration (Canada and United States). After registering, an email will be sent including...